Sign in Subscribe
Chairpersons

Zynex Appoints New CEO, Steven Dyson, to Drive Growth and Innovation

Strategic Insights

— 1 min read

As part of its effort to refocus on a more optimized payer mix and work towards a strong growth trajectory, Zynex, Inc. has announced the appointment of Steven Dyson as its new CEO. Dyson brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm. He has played a key role in acquiring, growing, and exiting numerous healthcare and medtech companies worldwide.

With a strong background in medical technology, Dyson will operate from Zynex's headquarters in Englewood, Colorado, while maintaining a residence in London, England. He holds a B.A. from Oxford University and a Ph.D. from Cambridge University.

Key Takeaways:

  • Steven Dyson, a seasoned medical technology executive, has been appointed as the new CEO of Zynex, Inc.
  • Dyson brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm.
  • His experience includes acquiring, growing, and exiting numerous healthcare and medtech companies worldwide.
  • Dyson's appointment aims to refocus Zynex's business strategy towards a more optimized payer mix and work towards a strong growth trajectory.
  • He will operate from Zynex's headquarters in Englewood, Colorado, and maintain a residence in London, England.
  • Thomas Sandgaard, the founder of Zynex, will remain actively involved as Chairman and Chair of the Board's Technology Committee.
  • Dyson's leadership experience includes companies such as KCI, Rodenstock, Healthium Medtech, Unilabs, and Neuraxpharm.

Statistics:

  • Zynex, Inc. was founded in 1996 and has developed, manufactured, marketed, and sold medical devices for pain management, rehabilitation, and non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals.
  • The company's CEO, Steven Dyson, has over 25 years of experience in the medical technology sector.
  • Zynex's current revenue mix and growth trajectory are expected to be refocused under Dyson's leadership.
  • Dyson's experience includes acquiring, growing, and exiting numerous healthcare and medtech companies worldwide.

Sources:

  • Zynex, Inc. press release (June 30, 2025 /PRNewswire/)
  • Zynex, Inc. website:
  • Securities and Exchange Commission filings, including the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

Read more